IgE CH3 peptide vaccine
US9216229B2 · kind B2 · utility
7Cited by
18References
14Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 29, 2013 |
| Grant date | Dec 22, 2015 |
| Priority date | — |
| Expiry date | Jul 24, 2033 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K2039/627
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to the provision of novel immunogens comprising an antigenic IgE peptide preferably linked to an immunogenic carrier for the prevention, treatment or alleviation of IgE-mediated disorders. The invention further relates to methods for production of these medicaments, immunogenic compositions and pharmaceutical compositing thereof and their use in medicine.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.